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Abstract
Deciphering protein structure and dynamics is a key prerequisite for understanding
biological function. The current work aims to apply HDX-MS to improve the
understanding of protein structure and dynamics for systems that remain challenging for
other techniques. Following a general overview of the field (Chapter 1), Chapter 2
investigates the relationship between enzyme dynamics and catalysis. By conducting
comparative HDX-MS measurements on rM1-PK during substrate turnover and in the
resting state, catalytically active rM1-PK undergoes significant rigidification of the active
site. However, virtually the same rigidification was seen upon exposing rM1-PK to
substrate or product in the absence of turnover. These findings demonstrate that
comparative experiments on enzyme dynamics by HDX-MS (and other bioanalytical
techniques) should be interpreted with caution. In Chapter 3, HDX-MS is used to probe the
intrinsically disordered protein Nrf2. HDX-MS is used to investigate the structure and
dynamics of the full-length Nrf2 and its interaction with the Kelch domain. The data
obtained demonstrate the highly-disordered nature of Nrf2. Its interaction with Kelch
causes protection of the binding sites on Nrf2, while the rest of the protein becomes slightly
more dynamic. This works highlights the limitations of using truncated protein constructs
when investigating their structure and dynamic properties using biophysical techniques.

Keywords: protein structure | conformational dynamics | electrospray ionization |
hydrogen/deuterium exchange | mass spectrometry | rabbit muscle pyruvate kinase |
catalysis | intrinsically disordered proteins | Nrf2 | Kelch
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Chapter 1 – Introduction
1.1 Proteins: Structure, Dynamics and Function
1.1.1 Protein Structure
Proteins are macromolecules that carry out essential physiological functions. Their
roles in biological systems include transport, catalysis, signaling, and cellular defense. The
biologically active structure of a protein is called their native structure. Historically,
proteins follow a classic structure-function paradigm. This model implies that the threedimensional structure of a protein is associated with a specific function.1 Therefore,
visualizing and understanding a protein’s three-dimensional native structure is key to
understanding the specific function they carry out.
Proteins are made up of amino acids. Amino acids are organic compounds that
contain an amine (-NH2), a carboxylic acid (-COOH), and a variable R-group (side-chain),
all of which are bound to a central CαH moiety shown in Figure 1.1a.2 Amino acids are
linked together by an amide bond (-OC-NH-), forming a polypeptide backbone (Figure
1.1b, shown in red). The linear sequence of amino acids constitutes the protein’s primary
structure. The chemical composition of the polyamide backbone permits hydrogen bond
(H-bond) formation between CO and NH groups. These H-bonds give rise to secondary
structures such as α-helices and/or β-sheets. The three-dimensional structure of a protein
is known as its tertiary structure. A protein’s native tertiary structure represents the lowest
free energy conformation, as governed by numerous bonding interactions between the sidechain groups and main chain moieties.3 In addition to H-bonds, these interactions include
hydrophobic interactions, disulfide bridges, salt bridges, and/or van der Waals contacts. In
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the native tertiary structure, nonpolar side chains form a hydrophobic core whereas the
hydrophilic side chains are found on the surface of the protein. Some proteins are made up
of multiple polypeptide chains. Depending on their subunit composition, these complexes
can be homo- or hetero-multimers. The quaternary structure refers to how the individual
subunits are arranged within the complex.

Figure 1.1. (a) Structure of an amino acid consisting of a central CαH, an amine, a carboxylic acid,
and a variable R group. (b) A polypeptide chain consisting of an N/C-terminus. The red bond
signifies the peptide bond formed between two amino acids.

1.1.2 Protein Folding
Protein folding is based on the classic principle that all the information required for
a protein to adopt the correct three-dimensional conformation is encoded in its amino acid
sequence. This concept was first discovered by Christian B. Anfinsen who demonstrated
the spontaneous refolding of RNase A into its active conformation with full return of
catalytic activity.4 Ever since, understanding the nature of protein folding has been a
compelling area of research and is commonly investigated by molecular dynamic (MD)
simulations5 and spectroscopic techniques.6 For a protein to fold, their sequence must
satisfy two requirements; a thermodynamic and a kinetic one.3,
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The thermodynamic

requirement is that the protein must adopt a unique folded conformation which is stable
under physiological conditions i.e. their native structure. The kinetic requirement is that
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the protein folding process to the native state must occur within a reasonable amount of
time i.e. typically within milliseconds to seconds.8-9
In order to describe the folding mechanism of proteins, the folding funnel model is
used. The energy landscape of a protein is in the form of a multidimensional “funnel” where
the vertical axis (depth of the funnel) represents the relative free energy of the
conformational space, and the horizontal axis corresponds to the conformational entropy
of the system.10 The native state of a protein resides in a local minima typically at the
bottom of the folding funnel with a low entropy and a global free energy minimum.11 This
model is based on the idea that there are many thermodynamic conformations in which the
free-energy landscape of a protein exhibits several local minima separated by barriers that
are associated with a specific polypeptide conformation. These local minima may result in
the transient formation of partially folded species, accumulation of intermediates, or
misfolded forms, depending on the trajectory taken by the protein along the energy
surface.12 The folding process involves a stochastic search of the many conformations
accessible to a polypeptide chain.13 As a polypeptide undergoes many conformational
changes, there is a significant decrease in the system’s conformational entropy as it
approaches the native state.14 Since there is a significant decrease in entropy as the protein
becomes conformationally restricted, the enthalpic gain of forming hydrogen bonds and
making favourable hydrophobic and hydrophilic contacts compensates for this entropic
penalty.10
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1.1.3 Protein Dynamics
The structure is an important aspect related to protein function however, it only
represents a static image of a specific native conformation. Proteins are not static entities
as they fluctuate naturally in solution. In recent years, it has become clear that in addition
to structure, the dynamics of proteins play a significant role in their function.15-16 HenzlerWildman et al demonstrated that enzymatic activity requires a precise balance between
flexibility and stability.17 To function, enzymes must be stable enough to retain their native
three-dimensional structure, but flexible enough to allow sufficient substrate binding.
Protein dynamics are involved in a wide range of functions including catalytic turnover of
enzymes, signaling/regulation, allostery, and some dynamics can enable some proteins to
perform multiple functions.18 In the case of catalytic turnover of enzymes, Eisenmesser et
al have shown that during catalytic action of the enzyme cyclophilin A, conformational
changes occurring in the active site are correlated with catalytic turnover of the enzyme.19
This finding exemplifies the importance of enzyme dynamics and how they pertain to their
catalytic function. Ultimately, protein function depends on their interaction with various
other molecules such as cofactors, ligands, or other proteins. Depending on the specific
molecules present and the physiological conditions, a protein can fluctuate between many
different conformations. Protein dynamics are characterized by the timescales and the
extent of the fluctuations.15 These dynamic changes can be outstandingly apparent or subtle
compared to their native conformation. The timescale and magnitude of protein dynamics
are tied to a set of temperature, pH and solvent conditions. These conditions can be
experimentally controlled to get a better understanding of the properties of protein
dynamics to fully understand the role they have on their function.
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Ultimately, the specific three-dimensional structure a protein adopts in its
biological setting controls the protein’s dynamic characteristics. This triad of structure,
dynamics, and function is being actively studied to attain a comprehensive understanding
of a protein’s role in biological systems.20-21

1.1.4 Enzymes
Enzymes are proteins that act as catalysts for virtually all biological reactions.
Enzymes are efficient catalysts that can accelerate reactions up to nineteen orders of
magnitude.22 They act by lowering the activation energy barrier of biochemical reactions,
thereby increasing the reaction rate. The factors that enable enzymes to provide the large
enhancement of reaction rates remain challenging to understand. Enzymes catalyze
reactions on a wide range of timescales which are similar to the time-scales of various
internal protein dynamics.17 It is well known that protein dynamics is an essential aspect
of enzyme function i.e., cofactor/substrate binding, catalytic conversion, and product
release. Understanding their internal protein motions may give insights into enzyme
catalysis.23-24
Enzymes are the key to carrying out biochemical processes, acting in a specific
sequence of events which enable them to catalyze reactions that degrade nutrients,
transform chemical energy, and synthesize biological macromolecules from simple
precursors.2 The activity of any given enzyme depends on several parameters such as
substrate concentration, temperature, and pH. Assuming that an enzyme catalyzes a onesubstrate reaction, the kinetics follow a simple mechanism shown in equation 1.1:
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𝑘1
𝑘2
𝐸 + 𝑆 ⇌ 𝐸𝑆 ⟶ 𝐸 + 𝑃
𝑘−1

1.1

This mechanism is characterized by a pre-equilibrium between the enzyme-substrate
complex (ES) and the enzyme (E) and substrate (S) with a rate of k 1 and k-1, respectively.
This is followed by an irreversible decay (k2) of the enzyme-substrate complex into the
enzyme and products (P).25 The Michaelis-Menten equation for this mechanism is
expressed in equation 1.2:

𝑣=

𝑉𝑚𝑎𝑥 . [𝑆]
𝐾𝑀 . [𝑆]

1.2

where ʋ is the rate of reaction, Vmax is the maximum reaction rate which can only be
enhanced by increasing the enzyme concentration, [S] is the substrate concentration, and
KM is the Michaelis constant that corresponds to the substrate concentration at ½ Vmax. If
[S] << KM the rate of reaction follows first order kinetics. If [S] >> KM, the reaction rate
will reach saturation according to equation 1.3:
𝑉𝑚𝑎𝑥 = 𝑘𝑐𝑎𝑡 ∙ [𝐸]𝑜

1.3

where kcat and [E] o is the turnover number of the enzyme and initial enzyme concentration,
respectively. [S], KM, and [E]o define an enzyme’s activity; these parameters are often
measured and reported to characterize enzyme kinetics under different conditions.
Enzymes are intricate chemical-reaction machines and they often require other
molecules to help carry out their function. These molecules are called cofactors. The most
common cofactors are metal ions. Common examples of such cofactors are Zn2+, Fe2+/3+,
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K+, and Mg2+. Cofactors can facilitate the following; binding and orienting the substrate in
the active site, formation of electrostatic contacts with reaction intermediates or they can
interact with a substrate to render them more electrophilic or nucleophilic.26 A subgroup of
cofactors called prosthetic groups are tightly integrated into the enzyme’s structure by
covalent or non-covalent interactions. These can be organic or inorganic molecules. Some
common examples of prosthetic groups are flavin nucleotides, pyridoxal phosphate, biotin,
or metal-containing porphyrins.

1.2 Methods for Studying Protein Structure and Dynamics
Numerous techniques are available to investigate the structure and dynamics of
proteins. All the various experimental methods have advantages/disadvantages and vary in
what type of information they can reveal about proteins and protein complexes.

1.2.1 X-ray Crystallography
X-ray crystallography is a technique that provides three-dimensional atomically
resolved structures from a crystal. This works by exposing a crystalline sample to an X-ray
beam. This process generates a unique diffraction pattern due to photon interactions with
electrons within the crystal. Measuring the intensities of the diffraction pattern can reveal
where the atoms are spatially located and this information is used to build a threedimensional structure.27
X-ray crystallography remains the gold standard for atomically resolved structural
data. RCSB Protein Data Bank (PDB) is a repository for three-dimensional biomolecular
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structural data. Over 100,000 structures have been determined by crystallographic
methods.28 RCSB PDB statistics show that crystal structures can routinely be resolved
under 2 Å. X-ray crystallography can be applied to protein complexes ranging all the way
to mega Daltons.29-30 Not only can this technique reveal high-resolution structures of large
protein systems, it can also be applied to protein-ligand, protein-protein, and protein-DNA
complexes.31
The main challenge associated with this technique is the crystallization process.
Not all proteins form high-quality crystals. For X-ray crystallography to be successful for
protein systems, the protein needs to be concentrated and high purity for a high quality,
homogenous crystalline material.32 For some protein systems, high concentrations can lead
to aggregation.33 As well, X-ray crystallography remains extremely challenging for
disordered proteins.27 Protein-protein contacts in crystal packing can differ from
physiological protein-protein contacts in solution.34 Overcoming the challenges of
crystallization remains the biggest roadblock for this technique.
Nonetheless, surpassing all the challenges of X-ray crystallography immaculate
structural data can be obtained. However, the data that is obtained only provides a static
snapshot of proteins in their native structure. This type of information provides very little
insight into their dynamics.15 Due to this pitfall, researchers have developed other
techniques that are able to provide high-resolution structural data as well as report on
dynamic properties of protein systems.
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1.2.2 Nuclear Magnetic Resonance Spectroscopy
Nuclear magnetic resonance (NMR) spectroscopy is a technique that utilizes
atomic nuclei that are intrinsically magnetic. For example, only selected isotopes such as
1

H, 13C, 15N, 17O, and 19F have a property called a spin. When spin-active nuclei is placed

in a magnetic field and radio waves are applied, the nuclei will absorb a certain amount of
energy. Due to this energy absorption at a given magnetic field strength, nuclei in different
chemical environments will resonate at slightly different frequencies. These frequencies
are reported as chemical shifts (δ) that are expressed in parts per million (ppm). As a result,
chemical shift values are unique to a certain chemical environment of a spin active nuclei.35
Numerous experiments can be designed to study changes to a particular chemical group
under different conditions.
In 1952, the Nobel Prize in Physics was awarded to Felix Bloch and Edward Mills
Purcell for their development of new methods for nuclear magnetic precision
measurements of bulk materials.36-37 Traditionally, NMR spectroscopy has been viewed as
an analytical technique for the characterization of small organic and inorganic molecules.
In 2002, Kurt Wüthrich won the Nobel Prize in Chemistry for developing the concept of
interrogating biological macromolecules in solution using NMR spectroscopy. With the
emergence of high-field magnets, this concept become possible to study macromolecular
structures using NMR spectroscopy. Ever since, NMR spectroscopy has emerged as a
major rival of X-ray crystallography for the determination of three-dimensional protein
structures.
Like X-ray crystallography, NMR spectroscopy can generate high-resolution
structural data on protein systems. However, NMR spectroscopy allows the determination
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of atomically resolved structures in solution under near-native conditions.38 Spin relaxation
experiments are commonly used to investigate protein dynamics. For example
experiments monitor the reorientation of

15

15

N

N – NH bonds, which are used to study

backbone dynamics or side chain motions of residues containing nitrogen.39 Methods have
also been developed that measure 2H relaxation properties at methyl (CH2D) and methylene
(CHD) side chain positions.40 Two-dimensional homonuclear and heteronuclear
experiments can be employed to help with spatial resolution of large protein systems.41-42
Another popular NMR technique used for studying conformational dynamics is amide
hydrogen/deuterium exchange (HDX).43-44
Since NMR spectroscopy has made many advances over the past half century, there
are challenging experiments that can be implemented to study large protein complexes
reaching 1 MDa.45 The routine application of NMR methods to large protein systems
(>40kDa) remains difficult. This is due to peak congestion, broadening, and overlap. Also,
NMR requires proteins to be stable at high concentrations (0.1 to 1 mM) for hours or days.46
Despite its size and concentration limitations, NMR spectroscopy remains a promising
technique to study the structure and dynamics of protein complexes.

1.2.3 Optical Spectroscopy
Optical spectroscopy techniques may be the most popular methods to study protein
complexes. This is due to their wide application, easy operation and their amenability to
almost all protein systems. All spectroscopic methods fall under the umbrella of low
resolution techniques. This is due to the fact that spectroscopic techniques provide some
insights into global structural changes while detailed structural features remain hidden.47
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1.2.3.1 Ultraviolet-Visible Spectroscopy
Ultraviolet-visible (UV-Vis) spectroscopy is an optical method used for many
biological applications. Ultra-violet and visible light cover the 200-400 nm and 400700 nm range, respectively, of the electromagnetic spectrum. When light of this energy
interacts with biological molecules, it produces an electronic transition where π electrons
or non-bonding electrons are promoted from their ground state to a high-energy state. The
most basic experiments utilize the protein’s side chain π bonds. The simplest example of
this is used in determining a protein’s concentration at wavelength 280 nm where the
aromatic side chains absorb light. This is determined by using Beer Lambert’s Law:
𝐴 = 𝜀∙𝐶∙𝑙

1.4

where A is the absorbance, ε is the molar absorptivity, C is protein concentration, and l is
the cuvette path length. If a protein contains an intrinsic chromophore, protein dynamics
and structural changes can be investigated using UV-Vis methods. This approach is
common for heme-containing proteins.48-49 Heme is a porphyrin ring that contains an Fe2+
or Fe3+ center. The Soret peak at ~400 nm is distinctive to heme-proteins.50 The spectral
features in this region can give information regarding conformational changes that occur
upon ligation or reduction/oxidation of the iron.51

1.2.3.2 Circular Dichroism Spectroscopy
Circular dichroism (CD) spectroscopy measures the differences in the absorption
of left- and right-circularly polarized light, a phenomenon that is generally encountered for
chiral molecules. One of the most important applications of CD spectroscopy is studying
the secondary structure of proteins. Different structural elements have characteristic CD

12

spectra in the 180-260 nm range. For example, spectra show unique minima for α-helices
at 208 and 222 nm, β-sheets at 218 nm, and random coils at 195 nm.52 CD spectroscopy
can also be used to examine protein tertiary structure in the region of 280-320 nm, although
this is less common.53 Overall, CD spectroscopy is best for investigating whether a protein
is folded, for monitoring the conformational stability of a protein under stress conditions
(temperature, pH, denaturants), and for observing whether intramolecular binding
interactions affect the secondary structure of a protein.54

1.2.3.3 Fluorescence Spectroscopy
Fluorescence spectroscopy studies protein behaviour in solution by monitoring
photons emitted from a sample after it has absorbed light. This process is mediated by
fluorophores with conjugated π bonds. Tryptophan (Trp) side chains are the most common
intrinsic fluorophore used as a structural probe since they are sensitive to changes in the
polarity of their environment.55 By measuring the emission of Trp at λmax=350 nm local
environment properties of the protein can be investigated. For example, Trp residues are
generally located in the core of a globular protein. However, when a protein becomes
partially or completely unfolded Trp becomes solvent accessible giving insight into the
overall structure of a protein. Many experiments can be employed to gain valuable
information on folding/unfolding processes, subunit association, and substrate binding.5657
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1.3 Mass Spectrometry
Mass spectrometry (MS) measures the mass-to-charge ratio (m/z) of gas phase ions,
allowing the implementation of a wide range of experiments. MS has become an important
tool in structural biology. Investigating protein systems using MS requires a soft ionization
(without fragmentation) technique to get biomolecules into the gas phase. Two ionization
techniques

that

are

used

for

studying

proteins

are

matrix-assisted

laser

desorption/ionization (MALDI) and electrospray ionization (ESI). In MALDI, the sample
is prepared by mixing with a solution of an energy-absorbing, organic compound called
matrix. When the matrix crystallizes upon drying, the sample within it co-crystallizes. The
matrix is then exposed to a laser pulse, where through desorption and ionization
analyte/matrix ions are produced.58 Today, MALDI is primarily used for imaging
applications. ESI has excelled as the preferred ionization technique to provide information
on protein’s solution-phase characteristics.59-60 ESI was used in this work and in the
following section it will be discussed in detail.

1.3.1 Electrospray Ionization
In the 1990s Fenn et al introduced the concept of ESI.61 ESI is a process that
permits the transfer of analytes from solution into the gas phase. Due to its ‘gentle’ nature,
it has prevailed as the choice of ionization that is necessary for numerous MS applications
particularly biological macromolecules.
ESI is initiated at atmospheric pressure by applying a high voltage to a metal
capillary that acts as an outlet for the analyte solution. ESI can work in both positive and
negative ion mode. In positive ion mode (that is exclusively used in this work), the high
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positive voltage applied causes charge separation (for example, due to oxidation of water;
2H2O → 4H+ + 4e- + O2),62 where electrons are removed from solution and the positively
charged ions will emerge at the end of the capillary outlet. At this outlet, the solution will
form a Taylor cone. Due to excess positive charge repulsion within the Taylor cone, the
liquid becomes unstable and produces a plume of small charged droplets. These droplets
undergo evaporation. The charge density on the shrinking droplet builds up until the
surface tension γ is balanced by Coulombic repulsion. This situation corresponds to the
Rayleigh limit, where the number (zR) of elementary charges e is given by63

𝑧𝑅 =

8𝜋
√𝜀0 𝛾𝑟 3
𝑒

1.5

where r is the droplet radius, and ε0 is the vacuum permittivity. Droplets at the Rayleigh
limit undergo jet fission into smaller progeny droplets. This process repeats itself through
several generations until desolvated gas-phase ions are released.64 ESI produces multiply
charged [M + zH]z+ gas phase ions. Due to the high charges states formed during ionization,
ESI has no upper size limit for studying proteins. Routinely ESI allows the transfer of kDa
to MDa proteins into the gas phase.65-66
Three different mechanisms have been proposed for the final steps of the ESI
process, i.e., the release of gas phase ions from nanometer-sized ESI droplets (Figure 1.2).
A mechanism that likely applies for low molecular weight species and atomic ions is the
ion evaporation model (IEM). This model envisions that direct emission of the analyte from
the droplet will occur after the droplet radius is less than 10 nm. It is suggested that by
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removing charge through this process, it suppresses the Coulomb fission of “late” ESI
droplets.64 Large globular proteins are released into the gas phase by the charged residue
model (CRM). This model suggests that analyte in a droplet evaporate to dryness. The
remaining charge in the solvent before the last evaporation step is believed to be transferred
to the protein.67 Kim et al recently demonstrated using MD simulations that peptides most
likely become gas phase ions through the CRM process as well.68 Lastly, unfolded proteins
are believed to proceed through the chain ejection model (CEM). Since an unfolded protein
will have solvent accessible hydrophobic residues, it will travel to the droplet surface where
it will get ejected while taking charge with it.69

Figure 1.2. A schematic illustrating how gas phase ions are produced through the electrospray
process through the IEM, CRM, and CEM mechanisms.
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1.3.1.1 Protein Analyses
The investigation of proteins by MS can be carried out in many ways. Due to the
gentle nature of ESI, some experiments investigate intact proteins from solution into the
gas phase. Most popularly though, many MS experiments study proteins on the peptide
level. These experiments involve the use of proteases, where proteins are enzymatically
digested and then analyzed by MS. Two common proteases used are trypsin and pepsin.
Trypsin cuts selectively after Lys and Arg residues.70 This is advantageous as relatively
few and well defined peptides are generated. For the analyses used in this work, pepsin
digestions were employed. Pepsin has a fairly non-selective preference for what sequence
it will cleave.71 Even though the digestion patterns are somewhat unpredictable, the
reproducibility of cleavage patterns is quite high under identical experimental conditions.72
The use of a proteases to create peptides prior to analysis with MS is termed a bottom-up
approach.
Since bottom-up approaches are commonly used, MS is routinely coupled with
liquid chromatography (LC). This “LC/MS” approach allows the desalting of peptides or
other analytes, allowing for higher quality mass analysis. As well, prefractionation of
analyte prior to mass analyses simplifies MS measurements.

1.3.2 Mass Analyzers
The mass analyzer is used to separate gaseous ions based on their m/z. Various
types of mass analyzers exist; these include quadrupoles, ion traps, Orbitraps, Fourier
transform ion cyclotron (FT-ICR), and time-of-flight (TOF) analyzers. Quadrupoles and
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TOF mass analyzers have been used in this work and will be discussed in detail in the
following sections.

1.3.2.1 Quadrupole Mass Analyzers
A quadrupole mass analyzer consists of four parallel cylindrical rods. Each pair of
opposing rods is always at the same electric potential. When a radio frequency (RF) voltage
is applied to the quadrupole, all ions with different m/z will pass through the quadrupole
and reach the detector as shown in Figure 1.3a. In this ‘RF-only’ mode, the quadrupole acts
as an ion guide.73 When both an RF and direct current (DC) voltage is applied to the rods,
the quadrupole only allows the transmission of a certain m/z. This is due to the ion’s stable
trajectory through the quadrupole, where it then reaches the detector. Ions with other m/z
values travelling through the quadrupole will have an unstable trajectory and collide with
the rods and become neutralized as shown in Figure 1.3b. The changing of these voltages
can result in the transmission of various m/z values.74

Figure 1.3. Schematic of a quadrupole mass analyzer. (a) In RF-only mode, all ions can be
transmitted through the quadrupole to the detector. (b) When a certain RF/DC ratio is applied to
the rods, only a specific m/z can pass through the quadrupole. All other m/z values will have an
unstable trajectory and eventually hit the rods and become neutralized.
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Quadrupole mass analyzers have relatively low resolution (~2000) but offer
excellent sensitivity.10 The m/z range of typical quadrupole MS is limited to 4000. Many
modern mass spectrometers use quadrupoles in combination with other ion optics elements.
Commonly, today they are used in Q-TOF (quadrupole time-of-flight) and TripleQuadrupole instruments for performing tandem-MS. When quadrupoles are used in
conjunction with another mass analyzer this increases the resolution of these instruments
by an order of magnitude.

1.3.2.2 Time-of-Flight Mass Analyzers
A TOF mass analyzer measures an ion’s m/z based on its flight time through a flight
tube. Ions are accelerated into the flight tube by an electric pusher pulse. This voltage pulse
gives all ions with the same m/z the same potential energy, which is converted into kinetic
energy.
𝐸𝑝𝑜𝑡 = 𝐸𝑘𝑖𝑛

𝑧𝑒𝑈 =

1
𝑚𝑣 2
2

1.6

1.7

Where U is the voltage pulse applied, v is the velocity of the ion, m is the mass of the ion,
and z is the charge state of the ion. From equation 1.7, the time t it takes for an ion to
traverse the flight tube with a length l and reach the detector is

𝑡=𝑙√

m 1
e z2U

1.8
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Demonstrated in equation 1.8, the flight time of an ion depends on its m/z. Ions with
different m/z values have different velocities. Ions with a smaller m/z will traverse the
flight tube faster than ions with a larger m/z. In reality, ions with the same m/z may have
different flight times as a result of the ions not receiving the exact same amount of energy
(U) in equation 1.7. This means their arrival time to the detector will vary. This time
difference leads to peak broadening. A reflectron is a device that is inserted into the flight
path to compensate for this deleterious effect.
A reflectron is an ion mirror that has an electric field applied to its electrodes. The
reflectron reverses the flight direction of ions to the detector. Faster ions with the same m/z
will penetrate deeper into the reflectron and their flight time will become longer. The flight
time of the two ions with the same m/z will be corrected and arrive at the detector at the
same time. The introduction of reflectrons into TOF instruments decreases ion transmission
however, it increases the resolution of these mass analyzers to routinely 50,000.

1.3.2.3 Tandem Mass Spectrometry
Tandem MS (MS/MS) is a technique that requires more than one mass analyzer.
For example, the first mass analyzer (MS1) selects ions of a particular m/z (parent ion) that
represents a single species from the ion source. These species are most commonly peptides.
The ions are accelerated through a collision cell containing inert gas (N2) to induce
fragmentation. In this work, this process is called collision-induced dissociation (CID). The
m/z values of the fragment ions are measured using the second mass analyzer (MS2).
Triple-quadrupole and Q-TOF instruments are most commonly used for tandem MS. A
schematic of the Q-TOF used in this work is shown in Figure 1.4.
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Figure 1.4. Electrospray ionization-mass spectrometer (Q-TOF) schematic used in this work. The
main components of this Q-TOF is; the T-Wave ion guide, quadrupole, Tri-wave, and the time-offlight detector.

In MS/MS experiments using this instrument, the quadrupole would be used for ion
selection, the TriWave would be used for CID equipped with N2 gas, and the generated
ions would be detected using the TOF mass analyzer.
Fragmentation of proteins or peptides cause backbone cleavage. During CID, the
peptide backbone will fragment once however, not all analytes will fragment in the same
place. In this case, two types of ions are generated from the parent ion. In CID, the most
common cleavage to occur is between the -OC-NH- bond resulting in b and y ions.75 These
ions are formed through cleavage of the peptide bonds, where b ions contain the N-terminus
and y ions contain the C-terminus as displayed in Figure 1.5. The numbering indicates what
peptide bond is being cleaved, counting from the N- or C-terminus.
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Figure 1.5. Nomenclature for b and y ions produced by CID. b ions (blue) contain the N-terminus
and y ions (red) contain the C-terminus. The number indicates what peptide bond is being cleaved
from the N- or C-terminus.

1.4 Structural Mass Spectrometry for Studying Protein Structure and
Dynamics
The establishment of ESI in the early 1990s has open the doors to a vast array of
MS methods to study macromolecular species. As the field evolves, structural MS
techniques are routinely used to investigate protein structure and dynamics with ultimately
no size limitations.

1.4.1 Native Mass Spectrometry
Native MS is a technique that is used to study intact protein complexes in the gas
phase. For studying proteins in their native form, their structure must be retained from
solution into the gas phase. Numerous examples in the literature show that proteins can
retain ‘native-like’ structures in the vacuum which has established the field of gas-phase
structural biology.76-78 Native MS is used to identify proteins, sample heterogeneity, ligand
binding, substrate turnover, structural topology, and dynamic properties of assembly.77, 79
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To perform native MS experiments, the protein needs to be in ammonium acetate at pH ~7.
The volatile nature of ammonium acetate (NH4+ (aq) + CH3-COO- (aq) → NH3 (g) + CH3
– COOH (g)) ensures that undesired adduct formation during ESI is minimized.80 Once the
protein complex is in the gas phase, various characteristics can be extracted from the mass
spectra collected. For example, folded compact structures will give rise to narrow charge
state distributions whereas unfolded conformers will generate a wide distribution of high
charge states.81
Many research groups perform native MS studies coupled with ion mobility
spectrometry (IMS).82 IMS separates ions in the gas phase based on their drift time through
an inert gas (N2 or He) under the influence of a weak electric field E.83 An ion with a more
compact structure will have a smaller drift time due to less collisions with the background
gas. In contrast, an unfolded structure will have a longer drift time.84 By measuring the
drift time td of ions with a charge z through a drift tube with length L, the collision cross
section (CCS) Ω can be calculated using equation 1.9.

Ω = 𝑧𝑡𝑑

𝑒𝐸

[

18𝜋 1/2 760 𝑇𝑜𝑟𝑟

16𝑁𝐿 𝜇𝑘𝑏 𝑇

]

𝑝

𝑇
273.2 𝐾

1.9

where N is the background gas number density, μ the reduced mass of the ion-neutral pair,
kb is the Boltzmann’s Constant, and T the gas temperature. This is another promising
technique that is commonly used to ensure the solution-phase native structure is preserved
in the gas-phase.85-87
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1.4.2 Covalent Labeling
Covalent labeling is a technique that investigates conformational changes through
modification reactions.88 Solvent accessible or exposed side chain sites will react more
quickly with probes or covalent labels compared to buried side chains on the protein.
Information about a protein’s structural changes is inferred from differential reactivity
patterns of individual amino acids.89 One commonly used covalent label is hydroxyl
radicals (˙OH).90 Quantitative analyses of labelled modifications to a protein are often
conducted at the peptide level where the protein undergoes a tryptic digest before MS
analyses. MS/MS experiments are employed to determine the labelled products.91

1.4.3 Covalent Cross-Linking
Like covalent labeling, chemical cross-linking also requires the addition of covalent
modifications to the protein. This technique uses a bifunctional “cross-linker” of a specific
length covalently coupled to two side chains on a protein that are separated by a certain
distance. Various cross-link spacer lengths can be used to investigate different distance
regimes.92-93 Lysine side chains are the most commonly used cross-linking target however,
other residues such as cysteine can also be used. The detection of cross-links using MS
provides information on both structure and the interactions of proteins and protein
assemblies.94 Cross linking techniques have even been applied in vivo.95-96
Before the cross-linked protein is introduced into the MS, a trypsin digest is
conducted. The analysis of cross-linked peptides can be difficult due to the low abundance
of cross-linked peptides and a large portion of unmodified peptides present. Large
databases have been created to help alleviate the analyses of cross-linking experiments.97
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1.4.4 Hydrogen Deuterium Exchange
The development of hydrogen/deuterium exchange (HDX) began more than half a
century ago.98 HDX techniques monitor the exchange of labile amide hydrogens along the
protein backbone with deuterons from D2O solvent. Areas of the protein that are highly
dynamic/unstructured or solvent accessible undergo fast exchange. In contrast, areas that
are involved in hydrogen-bonded networks or are occluded from the solvent will undergo
slower exchange. HDX can reveal various characteristics of a protein such as the presence
or absence of protecting structure at peptide resolution, and aspects related to kinetic and
thermodynamic stability.99 HDX was initially used with NMR detection due to the different
magnetic properties of 1H and 2H.72 Since their magnetic properties are quite different (1H
spin= ½ whereas 2H spin=1), 2H would be silent in 1H NMR and vice versa.100 This
approach is used to interrogate structural and dynamic properties of proteins and is still
employed today.101-102 However, in the early 1990s MS-measurements using HDX were
introduced.103 Since then, HDX has become an indispensable analytical tool that gives
insights into the structure and dynamics of proteins.
Due to the 1 Da mass difference between hydrogen and deuterium, the
incorporation of deuterium into a protein backbone is easily detected by MS. Figure 1.6
illustrates the workflow of a typical bottom-up experiment. The experiment starts with
dilution of the protein in D2O and the reaction proceeds for various time intervals ranging
from seconds to hours (continuous-labeling). The exchange reaction is quenched by
acidifying it to pH 2.4 and lowering the temperature to slow the exchange reaction down
by orders of magnitude.104 This is followed by online proteolysis by an acid-active enzyme.
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Pepsin is almost exclusively used for digestion however; some other enzymes can be used
as well.105 Subsequently, the peptides are separated by LC and analyzed by MS.

Figure 1.6. HDX workflow

The overall exchange mechanism for the backbone amides for a protein is usually
described as
𝑘𝑜𝑝
𝑘𝑐ℎ
𝑁 − 𝐻𝑐𝑙𝑜𝑠𝑒𝑑 ⇄ 𝑁 − 𝐻𝑜𝑝𝑒𝑛 → 𝑁 − 𝐷
𝑘𝑐𝑙

1.10

where kop, kcl, and kch are the rate constants for an opening, closing, chemical transition,
respectively. Each N-H group of the backbone has its own unique kop, kcl, and kch values.
This exchange process is mediated by opening/closing conformational fluctuations where
hydrogen bonds must be transiently broken.102
A freely exposed backbone amide hydrogen at pH 7 can undergo exchange with
deuterons as quickly as 1 second when in D2O.106 However, protected amide hydrogens
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(H-bonded or occluded from the solvent) rates spread over many orders of magnitude and
may take weeks to months to undergo exchange.99 The slow exchange rate of folded
proteins are a result of intramolecular bonding or the restriction of solvent accessibility.
The exchange rates of the slowest amide hydrogens can be reduced by 10-8 of their rates in
unfolded forms of the same protein.107

1.4.4.1 EX1 and EX2 Exchange Kinetics
The overall rate for this mechanism in equation 1.10 is given by kHDX. There are
two limiting regimes that explain the HDX kinetics from equation 1.10. These are referred
to as EX1 and EX2 kinetics. EX1 kinetics exhibits amide labeling that occurs during the
first opening event where kch >> kcl. The overall exchange rate for EX1 kinetics is simply
𝑘𝐻𝐷𝑋 = 𝑘𝑜𝑝

1.11

In contrast, in the EX2 regime the probability of isotopic exchange occurring during a
single opening event is small. It involves many opening/closing events to occur before
deuterium exchange occurs.108 Under EX2 conditions, kcl >> kch where the exchange
mechanism can be characterized by:
𝑘𝐻𝐷𝑋 = 𝐾𝑜𝑝 𝑘𝑐ℎ

1.12

where Kop = kop/kcl is the equilibrium constant for an opening event. Most proteins undergo
EX2 exchange kinetics under physiological conditions, while EX1 is quite rare. However,
EX1 kinetics can be induced by adding denaturants or by increasing the pH.109 There are
some examples where proteins can exhibit both EX1 and EX2 kinetics.110 These two
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regimes can be recognized by characteristic isotope patterns in mass spectra as shown in
Figure 1.7.111

Figure 1.7. A cartoon schematic of characteristic isotope patterns of EX2 and EX1 mass spectra.

1.4.4.2 Dependence of kch on pH and Temperature
The pH dependence of kch is an important factor for the design of HDX
experiments. An amide can exchange with solvent through acid-, or base-catalyzed
reactions with a kch expressed by equation 1.13
𝑘𝑐ℎ = 𝑘𝐻 [𝐻 + ] + 𝑘𝑂𝐻 [𝑂𝐻 − ]

1.13

where kH and kOH are the intrinsic rate constants for the acid- and base-catalyzed reactions,
respectively. Under physiological conditions, HDX proceeds with OH- (or OD-) catalysis.

28

The slowest exchange rates are observed around pH 2.4.104 At pH values lower than 2.4
deuteration takes place with H+ (or D+) catalysis. The temperature also plays a critical role
on the exchange kinetics. This relationship is dictated by the Arrhenius relationship

𝑙𝑛𝑘𝑐ℎ = 𝑙𝑛𝐴 −

𝐸𝑎
RT

1.14

where Ea is the activation energy for acid- or base-catalyzed exchanged (Ea(kH)=14 kcal
mol-1, and Ea(kOH)= 17 kcal mol-1); R is the gas constant, T is the temperature, and A is a
constant.
Manipulating the pH and temperature during HDX experiments is essential for
minimizing back-exchange. Back-exchange is an undesirable process where the deuterium
on the backbone gets exchanged back with hydrogen from the solvent. When protein
aliquots are removed after various time intervals, the pH is lowered to pH 2.4 to quench
the exchange reaction. The quenching process slows the exchange rate down by four orders
of magnitude. Decreasing the temperature to 0 ᵒC results in an additional ~14-fold decrease.
By simultaneously lowering the pH and temperature back exchange can thus be slowed by
five orders of magnitude.112 Chromatographic separation is performed at 0 ᵒC in acidified
mobile phase to minimize the back-exchange during LC runs. Side chains get labeled as
well during incubation in D2O however, these labels are removed due to quick ‘backexchange’ during LC separation. The back-exchange of side chains is beneficial since HDX
only measures the deuterium uptake of the amide hydrogens. All these different steps allow
enough time for the determination of the deuterium uptake by LC-MS.
Valuable information is obtained by comparing the deuteration kinetics for
different biochemical states of a protein. For example, this approach can be used for
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interrogating protein-ligand or protein-protein interactions.72 These interactions often
manifest themselves as a reduction in deuterium uptake rates113, although other scenarios
are possible.114 Soluble protein systems of all size remain routine for HDX experiments.
However, HDX protocols for membrane proteins are still developing even though major
advances have been achieved in the past few years.115-117 HDX-MS methodologies have
started to be exploited in the pharmaceutical industry in the development of
therapeutics.118-119

1.5 Scope of Thesis
Proteins play a central role in all biological systems. Understanding how a protein
functions has critical impact on many applications such as drug formulation, drug delivery,
and cancer and disease therapies.120-122 However, to fully understand a protein’s function
we must thoroughly understand their structure and dynamic characteristics. Many proteins
follow the classic ‘structure-function’ paradigm meaning that a well-defined threedimensional structure carries out a specific function. However, we know that proteins are
not only static structures but also dynamic entities. Their dynamic properties play a key
role in cofactor, ligand, and protein binding, having a direct impact on their functionally
relevant three-dimensional structure.
The objective of this thesis is to use HDX-MS as an analytical technique to
interrogate aspects of protein complexes that remain challenging with high-resolution
techniques. These efforts will provide insights into structural and dynamic features that are
related to the function of proteins that remain difficult to achieve with other techniques.

30

Chapter 2 investigates enzyme dynamics during catalysis. Structural fluctuations
are essential for all aspects of enzyme function, i.e., substrate binding, catalytic conversion,
and product release. It has been proposed that dynamics might be an ‘intrinsic’ property of
enzymes, implying that structural fluctuations should remain unchanged in the resting state
and during catalysis.123 Other cases have shown that enzymes exhibit enhanced dynamics
during catalysis.124 HDX-MS is used as a sensitive tool for interrogating enzyme dynamics.
HDX-MS comparative measurements are investigated during substrate turnover and in the
resting state on an enzyme called pyruvate kinase. These comparative measurements are
employed to give insights into the relationship between enzyme dynamics and catalysis.
Chapter 3 studies an intrinsically disordered protein (IDP) called nuclear factor
erythroid 2- related factor 2 (Nrf2). IDPs are unique as they do not follow the structurefunction paradigm. They have a high degree of dynamic flexibility and lack a well defined
three-dimensional conformation. Research shows that IDPs carry out their specific
function through protein-protein interactions where they undergo a disorder/order
transition where they are thought to adopt their biologically relevant conformation.125
High-resolution structural data on full length Nrf2 is not available. Many research groups
have tried to investigate full length Nrf2 but have been unsuccessful due to its dynamic
nature and its predisposition to aggregation during isolation and purification. HDX-MS is
used in this work to understand the disordered nature of full length Nrf2, and what effect
protein-protein interactions has on its structure and dynamics in the context of the fulllength protein.
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- Changes in Enzyme Structural Dynamics Studied
by Hydrogen Exchange-Mass Spectrometry: Ligand Binding
Effects or Catalytically Relevant Motions?

2.1 Introduction
The catalytic power of enzymes is remarkable, with rate enhancements up to
nineteen orders of magnitude to the corresponding uncatalyzed reactions.1 This
acceleration results from the lowered activation barriers, often in conjunction with the
breakdown of reactions into multi-step sequences.2-3 A central aspect of enzyme catalysis
is the stabilization of transition states in the active site by H-bonds, the careful positioning
of proton donors/acceptors, transiently formed covalent linkages, and the exclusion of
water.1, 4 Metal cofactors can provide electrostatic contacts, Lewis acid/base interactions,
and electron shuttling.5-6
Like

other

proteins,

enzymes

undergo

conformational

dynamics.

The

corresponding motions cover a wide range, from subtle picosecond side chain fluctuations
to major sub-second domain movements and unfolding/refolding transitions.7-9 Enzyme
dynamics are considered to be a key prerequisite for catalysis.3, 10-18 This view is reinforced
by X-ray data that show large structural changes upon binding of substrates or inhibitors,
compared to the catalytically inactive resting state.19-23 These crystallographically
detectable changes typically lead from an unbound “open” conformation to a “closed” state
where the substrate is occluded from the bulk solvent while catalysis takes place.
Subsequent product release requires and opening event, before the next turnover event
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commences.24 Steady-state turnover must therefore be accompanied by incessant
opening/closing transitions. Beyond binding and release, conformational fluctuations may
also mediate catalytically important contacts that promote bond formation/dissociation.3,
10-18

The exact implications of conformational dynamics for binding, release, and for the

reshuffling of chemical bonds nonetheless remains controversial.25-27
A seemingly straightforward approach for deciphering the relationship between
dynamics and catalysis is to compare the properties of working enzymes with those of the
resting state. Experiments on dihydrofolate reductase suggest that substrates channel
conformational motions along a specific reaction path.28 The internal dynamics of
chymotrypsin were reported to be enhanced during catalysis.13 In contrast, the dynamics
of thermolysin were indistinguishable during catalysis and in the resting state,29 supporting
the view that catalytically relevant motions are “intrinsic” and do not strongly depend on
the presence of substrate (as previously suggested for the nano- to millisecond dynamics
of adenylate kinase).30 Thus a consistent picture has not emerged yet.
The interpretation of active/resting state comparative data is complicated by the
fact that interactions with substrates, intermediates, or products may affect enzyme
dynamics in ways that are not directly related to catalysis. Protein-ligand interactions
generally affect the protein energy landscape, thereby altering conformational
preferences.31 Ligand-bound proteins are usually less dynamic than the corresponding apostates. This stabilization arises from the cooperative stabilization of intramolecular
linkages by intermolecular contacts.32-45 However, local or global destabilization can take
place as well.46-49 It is therefore not obvious if altered enzyme dynamics during turnover
are the result of catalytically relevant motions, of if they arise from rather trivial ligand
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binding effects. For deciphering these different scenarios, it is necessary to supplement
active/resting state comparisons with experiments that involve binding without turnover
(e.g. by providing only one of two required substrates, or by exposing the enzyme to
substrate mimics). It appears that the need for such control experiments has been underappreciated in the literature.
Pyruvate kinase catalyzes the glycolytic conversion of phosphoenolpyruvate (PEP)
and Mg-ADP to pyruvate and Mg-ATP. Four mammalian variants of this enzyme have
been identified.50-51 The L and R isoforms are found in liver and red blood cells,
respectively. M2 is expressed in embryonic tissues and during tumorigenesis,51-54 and it is
allosterically regulated by fructose-1,6-bisphosphate (FBP).55-56 The M1 isoform is found
in adult brain tissue and skeletal muscle,51, 53 it does not bind FBP and is constitutively
active under typical conditions.56
Rabbit skeletal muscle pyruvate kinase (rM1-PK) represents the most extensively
studied form of M1.22, 57-62 The 232 kDa protein has a homotetrameric quaternary structure.
Each subunit comprises four domains, termed N, A, B, and C. The active sites (one per
subunit) are located in clefts between domains B and A (Figure 2.1).22 Each active site
contains one K+ and one Mg2+ ion, for a total of two Mg2+ once Mg-ADP or Mg-ATP are
bound.63 The reaction (Figure 2.1b) involves binding of PEP and Mg-ADP with subsequent
phosphate transfer from PEP to Mg-ADP. Mg-ATP then departs, leaving behind pyruvate
in the enolate2- form which has its negative charges coordinated by Mg2+. Subsequent
ketonization of the enolate produces pyruvate and supplies much of the driving force for
the reaction.22, 55 X-ray structures provide insights into some of the events associated with
catalysis.22 Crystals were grown in the presence of Mg-ATP and oxalate. The latter mimics
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the enolate form of pyruvate.64 The data showed three subunit conformations, a fully closed
Mg-ATP/oxalate-bound state, a semi-open Mg-ATP/oxalate-bound structure, and an
oxalate-bound open conformation (Figure 2.1c-e). The open/closed transition involves a
41º rotation of domain B relative to A. These structures22 suggest that each turnover event
is accompanied by large-scale opening/closing events of the active site, making rM1-PK
an ideal model system for probing the relationship between dynamics and catalysis.

Figure 2.1. Crystal structure of rM1-PK (pdb code 1A49).22 (a) Complete tetramer. Each subunit
consists of four domains; N (cyan, residues 12-42), A (red, 43-115 and 219-387), B (green, 116218); C (blue, 388-530). The active site is located in the cleft between domains A and B. (b)
Catalytic reaction sequence, where the rM1-PK enzyme is denoted as “E”. Dots indicate
noncovalent protein-ligand contacts. Panels (c) – (e) illustrate active site closure for one of the
subunits via rotation of domain B after Mg-ATP (gray) and oxalate (magenta) bind. K+ and Mg2+
are shown in orange and yellow, respectively. (c) Closed state in the presence of Mg-ATP and
oxalate. (d) Semi-closed state in the presence of Mg-ATP and oxalate. (e) Open state in the presence
of oxalate, without nucleotide.
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NMR spin relaxation experiments are a well-established tool for probing enzyme
dynamics,28, 30, 65 but the application of this technique to systems as large as rM1-PK is
challenging. Also, NMR requires proteins to be stable at high concentrations (0.1 to 1 mM)
for hours or days. Hydrogen/deuterium exchange (HDX) mass spectrometry (MS)
represents an alternative approach13, 16, 29 that overcomes these limitations.35, 45, 66-68 HDXMS reports on conformational dynamics by probing the stability of backbone amide
hydrogen bonds. Segments that are tightly folded undergo slow deuteration, while flexible
and/or disordered regions exhibit much faster HDX (see Chapter 1).69 HDX-MS provides
an integrative view of fluctuations that take place on time scales of microseconds to
seconds.70 This technique has previously been applied to M1 and other pyruvate kinase
variants for probing allosteric regulation,57, 71-72 but not for examining the relationship
between dynamics and catalysis.
In the current work HDX-MS is used for characterizing the conformational
dynamics of rM1-PK during catalysis, in the resting state, and in the presence/absence of
various ligands that mimic different stages of the turnover process. The key question
addressed in these experiments is to what extent working/resting state comparative
measurements can provide information on catalytically relevant motions.

2.2 Methods

2.2.1 Materials
rM1-PK, Tris-Cl, ATP, ADP, potassium oxalate, rabbit muscle L-lactate
dehydrogenase (LDH) and deuterium oxide were purchase by Sigma Aldrich (St. Louis,

48

MO). KCl and MgCl2 were supplied by Fisher Scientific (Georgetown, ON). PEP and
NADH (disodium salt) were purchased from Roche (Mississauga, ON). Stock solutions of
metal-depleted rM1-PK were produced by protein incubation in 5 mM EDTA/50 mM TrisHCl with subsequent dialysis against 50 mM Tris-HCl with multiple buffer exchanges.
After dialysis, the rM1-PK concentration in the stock solution was 5 μM (as tetramer), as
verified by UV-Vis measurements at 280 nm. All solutions had pH 7.5 and all experiments
were carried out at room temperature (23  1 ᵒC), unless noted otherwise.

2.2.2 Enzyme Characterization
Several tests were conducted to verify the functional and structural integrity of
rM1-PK. Activity measurements73 were performed by monitoring the LDH-catalyzed
reduction of pyruvate to lactate by NADH. The conversion of NADH to NAD+ was
monitored by UV-Vis spectroscopy at 340 nm resulting in a kcat of 274  30 s-1 per rM1PK active site, which is close to the literature value of 250 s-1 per active site (Figure 2.2).74
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Figure 2.2. Pyruvate kinase activity was determined by the lactate dehydrogenase coupled assay.1
Reaction assays contained 50 mM Tris buffer, 100 mM KCl, 8 mM MgCl2, 1 mM PEP, 2 mM
ADP, 0.25 mM NADH, 2.5 μM lactate dehydrogenase, and 0.002 μM rM1-PK (as tetramer). The
reaction was initiated by adding 990 μL of the reaction mixture to 10 μL of rM1-PK. The assay
was run in triplicates, resulting in kcat= 274  30 s-1 per active site.

Native nanoESI-MS confirmed that the enzyme existed in its canonical tetrameric
quaternary structure shown in Figure 2.3.75
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Figure 2.3. Native nanoESI mass spectrum of rM1-PK (protein concentration 2.5 μM as tetramer,
metal-depleted sample) in aqueous solution containing 50 mM ammonium acetate, showing various
charge states of the protein tetramer. ESI capillary voltage 1.8 kV, sample cone 175 V, extraction
cone 3 V, source temperature 80 ᵒC, desolvation temperature 200 ᵒC. Similar data have been
reported previously.2

Mass spectrum recoreded under denaturing conditions showed monomers with a measured
mass of 57956  3 Da, consistent with the rM1-PK sequence (Uniprot identifier
PKM1/P11974-1) after loss of the N-terminal methionine and subsequent N-terminal
acetylation (57959 Da, Figure 2.4).76 These findings imply that the HDX kinetics discussed
below are dominated by native functional rM1-PK; any “contaminating” contributions
caused by degraded protein are minimal.
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Figure 2.4. ESI mass spectrum of denatured 5 μM monomeric rM1-PK acquired after passing the
protein through a C4 column using a water/acetonitrile gradient in the presence of 0.1% formic
acid. (a) Complete mass spectrum. (b) Deconvoluted mass distribution, resulting in a measured
protein mass of 57956  3 Da. The red dashed line indicates the calculated mass of the protein
(57959 Da) after loss of Met1 and N-terminal acetylation.3

2.2.3 Solution Conditions
Unless noted otherwise, all experiments were performed in 50 mM Tris buffer, 100
mM KCl, and 8 mM MgCl2 at pH 7.5 with rM1-PK concentration of 0.125 μM (as
tetramer). This salt environment has previously been shown to be adequate for ensuring
rM1-PK activity.77 Different types of samples were tested. (i) In the absence of any other
solutes, the aforementioned solution conditions provide the rM1-PK resting state. (ii)
Working state experiments were conducted in the presence of 10 mM ADP and 7.5 mM
PEP. Both of these concentrations are well above the KM values of the two substrates,
KM(PEP) = 0.07 mM, KM(ADP) = 0.3 mM.78 The time period during which the enzyme
maintains turnover can be estimated as (limiting substrate concentration)/(kcat  active site
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concentration) = 7500 μM / (274 s-1  0.5 μM)  1 min. Keeping the enzyme in the working
state for a longer time interval would require higher substrate concentrations.
Unfortunately, this was not possible due to ADP-mediated suppression of peptide signals
after peptic digestion. Some signal suppression was already apparent at an ADP
concentration of 10 mM, but the effect was still tolerable. An alternative strategy to extend
active state conditions would be to lower enzyme concentrations, but this would result in
undesirable loss of S/N ratio during MS analysis. (iii) Substrate binding experiments were
performed in the presence of either 2 mM ADP or PEP. (iv) “Product” binding experiments
were performed with 5 mM ATP and/or 1 mM potassium oxalate. These ligand
concentrations mirror those used in crystallization experiments of the corresponding bound
states.22 (v) Metal-depleted rM1-PK (produced by dialysis in the presence of EDTA, see
above) was studied in 50 mM Tris buffer; for K+ and Mg2+ binding experiments the
solutions were supplemented with 100 mM KCl or 8 mM MgCl2, respectively.

2.2.4 HDX-MS
Deuteration was carried out in 90% D2O at pD 7.5 (pD = pH meter reading + 0.4).79
Aliquots were removed at various time points (0.1, 1, 10, 30, and 100 minutes) after
initiation of deuteration. The aliquots were quenched by lowering the pH to 2.4 using 10%
(v/v) formic acid (FA) and flash freezing in liquid N2. The samples were thawed and
injected into a nanoACQUITY UPLC equipped with HDX technology (Waters, Milford,
MA). Digestion was carried out online using a POROS pepsin column (2.1 mm  30 mm)
from Life Technologies/Applied Biosystems (Carlsbad, CA) held at 15 ºC. Subsequently,
the peptides were trapped on a C18 BEH130 VanGuard column (5 mm  1 mm, 1.7 μm) for
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two minutes. Peptides were separated on a C8 BEH130 column (50 mm  2.1 mm, 1.7 μm)
at 90 μL min-1 using a water/acetonitrile gradient with 0.1 % FA. The LC outflow was
directed to a Waters Synapt Q-TOF G2 ESI mass spectrometer. The instrument was
operated using a capillary voltage of +2.8 kV and a cone voltage of 20 V. The desolvation
and source temperatures were set to 250 ºC and 80 ºC, respectively. Mass spectra were
acquired in resolution mode. Traveling-wave ion mobility separation was employed to
separate overlapping peptides.68 Peptides were identified using MSE acquisition in the
absence of D2O. MSE data were analyzed using ProteinLynx Global Server 2.5.3. All
software-based peptide assignments were verified manually. Online digestion yielded 108
peptides with a sequence coverage of 74.4% for the working state. All other states yielded
125 peptides, corresponding to a sequence coverage of 80.4%. As noted earlier, this
difference results from ADP-induced peptide signal suppression in the working state.

2.2.5 Data Analysis
DynamX 3.0 (Waters) was used for HDX data analysis. Deuterium levels were
corrected for artificial in-exchange and back-exchange using unlabeled (m0) and full
deuterated (m100) control samples, respectively. The latter were produced by incubation of
acid-denatured rM1-PK at pD 2.4 in 90% D2O for 15 h at 37 ºC. Deuterium uptake for each
peptide at labeling time t was calculated as:
𝑚𝑡 −𝑚0

% D(t) =𝑚

100 −𝑚0

x 100%

Residue numbering refers to the Uniprot sequence PKM1/P11974-1, which has the Nterminal methionine as residue 1 (MSKSH…). This is in contrast to some other studies22
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where the subsequent Ser2 was considered to be the first residue (SKSH…). Error bars
represent standard deviations derived from three independent sets of experiments for each
solution condition.

2.3 Results and Discussion

2.3.1 Conformational Dynamics During Catalysis
HDX-MS measurements on rM1-PK were carried out under various conditions. In
all cases the K+/Mg2+- saturated resting state served as reference. Data for the working
enzyme was obtained by monitoring deuterium incorporation into rM1-PK while the PEP
+ Mg-ADP → pyruvate + Mg-ATP conversion proceeded in solution. As noted in the
Methods section, these turnover conditions could be maintained for one minute. HDX-MS
yielded information on the deuteration behaviour of peptides throughout the protein, but
particular attention was focused on three segments located in the active site (Figure 2.5a).
Segment 110-123 binds K+ and is in contact with the phosphate groups of Mg-ADP or MgATP. Also, this region forms part of the hinge that allows for the movement of domain B
relative to A during turnover. Segment 292-298 accommodates the non-nucleotide Mg2+,
and it interacts with PEP and pyruvate (or oxalate in the crystal structure).22, 55 Segment
365-374 interacts with the adenine moiety of Mg-ADP or Mg-ATP.

55

Figure 2.5. (a) Locations of peptide 110-123, 292-298, and 365-374 in the rM1-PK active site.22
Unprocessed mass spectra of segment 365-374 after 1 min of HDX are shown for the resting state
(b), and under working conditions with substrate turnover (c). Vertical red dashed lines in panels b
and c represent isotope distribution centroids.

Mass spectra for segment 365-374 in the resting state and under working conditions
for t = 1 min are shown in Figure 2.5b and c. Even without detailed analysis, it is apparent
that working conditions caused significantly reduced deuteration compared to the resting
state. After normalization (see Methods), it was found that the deuteration difference for
segment 365-374 at t = 1 min was 36%. Even for measurements taken after 6 s this segment
already showed a deuteration difference of 18% (Figure 2.6c). Reduced HDX levels under
working conditions were also observed for the active site peptide 110-123 and 292-297,
although the differences were not as dramatic as for 365-374 (Figure 2.6a, b).
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Figure 2.6. HDX kinetic plots for selected rM1-PK peptides found in the active site (110-123, 292298, and 365-374, as noted along the top) under working conditions. (a-c) Comparison of resting
state (gray) and working (black) state.

For visualizing the HDX response across the entire protein the measured
deuteration differences were mapped to the crystal structure (Figure 2.7). All colour maps
in the following sections use a scale where blue indicates regions that are less dynamic (i.e.
with less deuteration) than the resting state and segments shown in red are more dynamic,
as indicated in the legend of Figure 2.7. Figure 2.7 reinforces the finding that peptides in
the vicinity of the active site exhibited strongly reduced deuteration under working
conditions. Slightly elevated HDX levels (~10%) were seen in some domain B segments
after 1 min, while the N and C domains were not affected.
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Figure 2.7. HDX difference plot for the working state at t = 1 min relative to the resting state, i.e.,
[%D(current state) - %D(resting state)], mapped to the crystal structure of one (closed) rM1-PK
subunit. The ligands shown represent the available crystal structures22 and do not always
correspond to the ligands present in the working state experiment.

The reduced deuteration in the rM1-PK active site during catalysis is unexpected.
Studies on other enzymes under turnover conditions found that structural dynamics were
enhanced,13 altered,28 or unchanged.29-30 Turnover-induced rigidification of the H-bonding
network, as observed here for rM1-PK, has not been previously reported. From the
measured kcat it can be estimated that each subunit undergoes 274 s-1  60 s  16,000
turnover events during the experimental time window, which must be accompanied by at
least as many active site opening/closing transitions (Figure 2.1c, e). One might have
expected that these large-scale movements contribute to enhanced dynamics in the active
site or in the domain B/A hinge region during turnover (Figure 2.1c-e). However, this
expectation is not confirmed by the experimental data. Several earlier studies indicated that
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reduced conformational dynamics generally suppress catalytic efficiency.16-17,

80

The

rigidification seen here for catalytically active rM1-PK thus seems counterintuitive,
considering the widely-accepted paradigm that conformational fluctuations are a
prerequisite for enzyme function.3,

10-18

Due to this observed behaviour, a thorough

examination of the response of the protein to the presence or absence of a range of
mechanistically relevant ligands, is described in the following sections.

2.3.2 Substrate Binding
Catalytic turnover by rM1-PK requires the presence of both PEP and Mg-ADP
(Figure 2.1b). By adding just one of these compounds it is possible to examine changes in
enzyme dynamics in response to substrate binding, as opposed to turnover. HDX-MS
profiles measured upon addition of PEP (green) showed markedly reduced deuteration in
a number of peptides, particularly 292-298 and 365-374 in the active site (Figure 2.8b, c).
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Figure 2.8. HDX kinetic plots for selected rM1-PK peptides found in the active site (110-123, 292298, and 365, as noted along the top) under substrate binding conditions. (a-c) Comparison of the
resting state (gray), PEP only (green) and Mg-ADP only (purple) states.

The magnitude and spatial distribution of the PEP-induced changes resembled the effects
seen under turnover conditions (Figure 2.9a). The addition of Mg-ADP (without PEP) only
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caused relatively minor changes in the deuteration behaviour relative to the resting state
displayed in Figure 2.9b.

Figure 2.9. HDX difference plots for substrate binding at t = 1 min relative to the resting state,
mapped to the crystal structures of one (semi-closed) rM1-PK subunit. (a) PEP binding, and (b)
Mg-ADP binding. The ligands shown represent the available crystal structures22 and do not always
exactly correspond to the ligands present in the substrate binding experiments.

2.3.3 “Product” Binding
Next, investigations into characterizing the response of rM1-PK to reaction
products in the solution was performed. The canonical products are pyruvate and Mg-ATP.
However, the binding affinity of rM1-PK to pyruvate is low such that unreasonably high
concentrations (>> 10 mM) would be required to achieve significant levels of bound
complex.22 The tendency of pyruvate to dimerize under such conditions would cause
additional complications.81 Following earlier crystallographic studies on rM1-PK,22 the
protein was exposed to oxalate, which has a much higher binding affinity than pyruvate.

60

Oxalate mimics the enolate that is transiently formed in the active site as an obligatory
intermediate during PEP → pyruvate conversion (Figure 2.1b)
Shown in Figure 2.10, exposure to Mg-ATP (purple) caused only minor changes in
the deuteration behaviour of rM1-PK relative to the resting state. In contrast, the presence
of oxalate (green) significantly lowered deuteration levels in the active site. Even more
pronounced effects were seen when both species were present simultaneously,
demonstrating that oxalate and Mg-ATP stabilize the active site H-bond network in a
synergistic fashion (Figure 2.10 a and c, blue).
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Figure 2.10. HDX kinetic plots for selected rM1-PK peptides found in the active site (110-123,
292-298, and 365, as noted along the top) under “product” binding conditions. (a-c) Comparison
of the resting state (gray), oxalate only (green), Mg-ATP only (purple), and oxalate + Mg-ATP
(blue).

The HDX difference maps generated for the oxalate and oxalate/Mg-ATP-bound protein
(Figure 2.11a, c) closely resemble that of the working enzyme (Figure 2.7). In all three
cases, the blue-coloured regions in domain A reflect a rigidification of the H-bond network
in the vicinity of the active site.
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Figure 2.11. HDX difference plots for product binding at t = 1 min relative to the resting state,
mapped to the crystal structures of one (semi-closed) rM1-PK subunit. (a) Oxalate binding; (b)
Mg-ATP binding; and (c) Oxalate + Mg-ATP. The ligands shown represent the available crystal
structures22 and do not always exactly correspond to the ligands present in the product binding
experiments.

2.3.4 Effects of Metal Cofactors
To further characterize the response of rM1-PK to intermolecular contacts the
consequence of K+ and Mg2+ depletion, being aware of the fact that such conditions are not
necessarily relevant in a physiological context, was examined. K+/Mg2+ depletion induced
dramatically increase deuteration in the active site where the metal binding sites are located
(Figure 2.12a-c). Other protein regions were affected to a much less extent (Figure 2.13a).
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Figure 2.12. HDX kinetic plots for selected rM1-PK peptides found in the active site (110-123,
292-298, and 365, as noted along the top) under metal binding conditions. (a-c) Comparison of the
resting state (gray), metal-depleted rM1-PK (black), K+ only (orange), and Mg2+ only (red).

Upon supplementing the metal-depleted protein with K+ or Mg2+ it was found that the latter
was more effective in terms of restoring stability of the H-bonding network (Figure 2.13b,
c). This behaviour is consistent with the fact that divalent ions usually interact more
strongly with proteins than monovalent species.5 In rM1-PK the non-nucleotide Mg2+ is

Figure 2.13. HDX difference plots for metal binding at t = 1 min relative to the resting state,
mapped to the crystal structures of one (open) rM1-PK subunit. (a) Metal-depleted rM1-PK; (b) K+
binding; and (c) Mg2+ binding. The ligands shown represent the available crystal structures22 and
do not always exactly correspond to the ligands present in the metal binding experiments.
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tightly chelated by Glu273 and Asp296, while K+ binds Asp113 and interacts with two side
chains and one main chain oxygen.22

2.3.5 Ligand-Induced Active Site Stabilization vs. Catalytically Relevant Motions
The HDX-MS binding experiments described above reveal the H-bond fluctuations
of rM1-PK are strongly affected by the presence of ligands. Binding to PEP, oxalate, or
oxalate/Mg-ATP cause significant stabilization of the active site. This ligand-induced
stabilization suggests that the active site follows an induced-fit scenario, where pliable
elements fold around the ligand. Such behaviour has previously been documented for many
other protein-ligand interactions.82-83 In all these cases, intermolecular contacts trigger
conformational changes that stabilize the protein scaffold surrounding the ligand
recognition site.32-45 The high sensitivity of the active site for ligand-induced stabilization
is further emphasized by the finding that Mg2+ removal dramatically increase the extent of
deuteration, implying that metal binding is subject to induced behaviour as well.
Close inspection of Figure 2.9 and Figure 2.11 colour maps reveal red hues in
domain B, indicating that his region which is somewhat remote from the active site, shows
a slight destabilization in the presence of catalytically relevant ligands. This behaviour is
consistent with earlier reports that ligand binding can cause stabilization as well as
destabilization in different protein regions.46-49
Strikingly, the HDX patterns observed upon binding of PEP, oxalate, or
oxalate/Mg-ATP under conditions that preclude substrate turnover (Figure 2.9a and Figure
2.11a, c) are very similar to the HDX pattern observed under working conditions (Figure
2.7). From this finding it is concluded that changes in the rM1-PK H-bonding network seen
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under working conditions primarily reflect the protein response to binding interactions,
rather than the occurrence of catalytically relevant enzyme motions. In other words, Hbond stabilization during catalysis arises from the fact that the protein cycles through
various ligand-bound states under working conditions (EPEPMg-ADP, EenolateMgATP, Eenolate, see Figure 2.1b) These observations imply that interactions with PEP and
enolate are primarily responsible for the rigidification during catalysis, while the presence
of Mg-ADP and Mg-ATP has less pronounced effects on H-bond stability.
Very minor differences are apparent between the working state HDX map (Figure
2.7) and the data obtained for PEP, oxalate, and oxalate/Mg-ATP-bound states (Figure 2.9a
and Figure 2.11a, c). However, attempts to interpret these small effects as a signature of
unique catalytic motions would be unjustified, keeping in mind that no ligand-bound state
will ever represent a perfect comparator for the working enzyme.
It is not disputed that conformational dynamics play a role for the rM1-PK catalytic
mechanism, as implied by the closed/open crystal structure of Figure 1 c and e.22 In addition
to these large domain movements, small-scale fluctuations may facilitate the chemical
conversion steps taking place during catalysis.17 However, the HDX-MS data fail to
uncover the presence of any conformational events that are uniquely linked to catalysis.
Rather, the deuteration kinetics are dominated by ligand-induced stabilization that is
encountered regardless whether turnover takes place or not. Any efforts to specifically
identify catalytically relevant motions within the wide spectrum of rM1-PK dynamics8-9
are hindered by the masking contributions of rather mundane ligand binding effects.
Clearly, binding-induced stabilization is associated with rM1-PK catalysis, but this
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stabilization does not represent a unique feature of the catalytically active protein because
the same stabilization effects can be induced in the absence of turnover.

2.4 Conclusions
The question addressed in this work is whether working/resting state comparative
HDX-MS measurements can provide direct information on the nature of catalytically
relevant enzyme motions. This concept is analogous to trying to decipher the inner
workings of an industrial assembly line by examining a factory on a Sunday when the
machinery is on standby, followed by a comparative inspection during the week when raw
material is converted to product. Within this simple analogy, it will undoubtedly be
possible to uncover how motions of individual machine parts contribute to the overall
turnover process.
In the case of enzymes, the situation is more complex. Incessant thermal motions
take place on a wide range of length and time scales, as proteins cycle through their
Boltzmann-allowed conformational space.8-9 Some of these fluctuations may be
catalytically relevant, while others represent unproductive “noise”. Catalytically relevant
motions may be facilitated by the presence of substrate in the active site,13, 28 while others
are intrinsic.29-30 During enzymatic turnover there will be a certain fraction of time during
which the active site is bound to substrates, intermediates or products; these bound
conditions will alternate with periods where the active site is vacant and primed for the
binding of new substrates that would initiate the next turnover cycle. When aiming to
design comparative measurements for identifying motions that are uniquely linked to
catalysis, it may be impossible to select a suitable state against which the working enzyme
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can be appraised. The resting state is not appropriate because it lacks pertinent ligandprotein interactions. On the other extreme, binding of catalytically relevant species to the
active site without turnover (as in Figure 2.9 and Figure 2.11) results in ligand-protein
interactions that are much more permanent than those encountered during turnover. Neither
condition provides a proper comparison base, which is why HDX difference maps will
generally not reveal dynamic features that are uniquely linked to catalysis. Other enzymes
may be less prone to binding-induced alterations than rM1-PK,29-30 but this does not imply
that differences seen in working/resting state comparisons for those other systems will
necessarily pinpoint catalytically relevant motions.
Overall, the current work demonstrates that efforts to elucidate linkages between
enzyme dynamics and catalysis via comparative measurements should be treated with
caution, although there is no shortage of such experiments in the literature. This conclusion
is not limited to HDX/MS but also applies to other bioanalytical tools. In the case of rM1PK, dramatic changes were observed in the extent of conformational dynamics during
catalysis. These changes are not unique to catalysis, but they arise from binding interactions
that can also be implemented in the absence of turnover (compared in Figure 2.14).
Comparable binding-related stabilization32-45 (or destabilization)46-49 effects have been
reported for non-enzymatic proteins. Based on current available data it appears that the
magnitude of such binding-associated dynamic changes dwarfs subtle conformational
events that might be uniquely linked to enzymatic turnover.

67

Figure 2.14. Dynamic changes observed during catalysis are quite similar to dynamic changes
observed upon ligand binding.
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Chapter 3 – Protein-Protein Interactions in the Antioxidant
Pathway: Probing the Disordered Nature of Full-length Nrf2
Using Hydrogen/Deuterium Exchange-Mass Spectrometry

3.1 Introduction
Intrinsically disordered proteins (IDPs) have a high degree of dynamic flexibility
and lack a well-defined three-dimensional conformation. IDPs can have isolated disordered
domains but in many cases this disorder extends to the entire protein in which case it is
called ‘natively’ unfolded.1-2 Characteristic of IDPs is their low level of sequence
complexity and that their sparsity of hydrophobic and bulky residues result in the absence
of a tertiary structure.3 Due to their distinctive sequences, it is relatively straightforward to
develop computer-based algorithms to identify these types of proteins in biological
databases.4-5 These algorithms have shown that IDPs encompass roughly one third of all
known proteins in eukaryotic organisms.6
Many proteins conform to the classical structure-function paradigm, where a
distinct sequence gives rise to a well-defined three-dimensional structure that is closely
associated with a biological function (e.g., in the case of enzymes, see Chapter 2). IDPs do
not follow this classic structure-function paradigm, since they lack a well-defined threedimensional structure. This makes it difficult to understand their structural and dynamic
characteristics as it is often the disordered regions that carry out their specific function by
mediating protein-protein interactions.7-9 The disordered regions involved in these
interactions usually undergo a disorder/order transition, .i.e., they adopt their biologically
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relevant conformation upon target binding.10-11 IDPs interact with their targets with
relatively high specificity and low affinity.12 This process allows them to associate rapidly
with their binding partners and a initiate a process, but they can also dissociate easily when
this process is completed.13
IDPs play a crucial role in transcriptional regulation, translation and cellular
signalling resulting in the activation/deactivation of certain genes.14 One important
example of this is cellular protection under endogenous or xenobiotic stressors such as
reactive oxygen species (ROS), heavy metals, or other electrophilic stressors.15 When large
quantities of these cytotoxic species are present in cells, a mechanism is implemented to
eliminate them to avoid cell damage which could lead to impaired cellular function.
Specific proteins are involved in activating certain genes that encode cytoprotective
enzymes. One protein that plays a key role in the activation of cytoprotective genes is the
nuclear factor erythroid 2- related factor 2 (Nrf2).
Nrf2 is a 68 kDa protein that plays an important role in resistance to oxidative and
electrophilic stress. It is a member of the cap ‘n’ collar subfamily of basic leucine zipper
(bZIP) transcription factors. Research has shown Nrf2 plays a crucial role in cancer,
neurodegenerative diseases, and many autoimmune and inflammatory disorders.16-19
Distinctive to bZIP transcription factor proteins, Nrf2 consists of seven conserved domains
displayed in Figure 3.1. Neh1 contains the bZIP DNA binding and heterodimerization
domain through which Nrf2 interacts with small musculoaponeurotic fibrosarcoma (Maf)
proteins in the nucleus. Neh2 contains a low affinity binding site (sequence DLG) and high
affinity (ETGE) binding site that interact with Kelch-like ECH-associated protein 1
(Keap1). Each binding site on Nrf2 interacts with a separate Keap1 protein resulting in a
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1:2 binding stoichiometry. Neh3-5 are involved in binding other transcription factors in the
nucleus. Neh6 contains two redox-independent motifs that are targeted for degradation of
Nrf2.20 Lastly, Neh7 is involved in the interaction with the DNA-binding domain of
retinoic X receptor α that has been believed to supress Nrf2.21-23

Figure 3.1. The position and residue numbering of Nrf2’s seven conserved domains. Neh2 contains
a low (DLG, residues 29-31) and a high (ETGE, residues 79-82) affinity binding motif that interact
with two separate Keap1 proteins.

Keap1 is a 70 kDa protein that belongs to the BTB-Kelch family. Keap1 consists
of four domains; the N-terminal Broad complex, Tramtrack, and Bric-a-Brac (BTB)
domain, central intervening region (IVR), Kelch domain, and the C-terminal region shown
in Figure 3.2. The N-terminal BTB domain is involved in homodimerization of Keap1. The
central intervening domain is rich in cysteine, making this region redox sensitive. Lastly,
the C-terminal Kelch domain is involved in interacting with Nrf2 through the ETGE and
DLG motifs.24-25

Figure 3.2. Keap1 domains. BTB domain (red), IVR domain (gray), Kelch domain (blue), and the
C-terminal region (yellow). Two separate Kelch domains are involved in the interaction with Nrf2’s
low and high affinity binding motifs.
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Under normal conditions (Figure 3.3a), Nrf2’s DLG and ETGE motifs interact with
Keap1 in a 1:2 ratio of Nrf2:Keap1 in the cytoplasm. When Nrf2-Keap1 interact with each
other, this results in the polyubiquitination of Nrf2. Due to polyubiquitination of the Nrf2Keap1 complex, Nrf2 is rapidly degraded by the 26S proteasome, with a short half-life of
approximately 20 minutes in the cytoplasm.26

Figure 3.3. Nrf2-Keap1 redox control pathway. (a) Under normal conditions, Nrf2 and Keap1
interact in the cytoplasm, which results in the polyubiquitination of Nrf2. This leads to the
degradation of Nrf2 by the 26S proteasome. (b) Under stressed conditions, Keap1 is redox sensitive
protein where specific thiols become modified under oxidative or electrophilic stress, this alters the
Nrf2-Keap1 complex. This causes the DLG motif to dissociate which results in the accumulation
of new synthesized Nrf2 in the cytoplasm where it can then enter the nucleus and bind the respective
target gene.

Keap1 is a cysteine rich protein that acts as a redox sensor under
oxidative/electrophilic stress primarily in its IVR. Keap1 contains numerous reactive
cysteines with a pKa value around 4-5 due to the microenvironment of the surrounding
amino acids.27 Therefore, at physiological pH, these reactive cysteines exist as thiolate
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anions (RS-).28 When a cell is under oxidative/electrophilic stress, certain cysteines are
more reactive towards specific stressors. Modification of cysteines (for example, formation
of disulfide bonds) on Keap1 alter the structure of the Nrf2-Keap1 complex. This causes
the lower affinity DLG binding site to dissociate from Keap1, subsequently inhibiting
polyubiquitination of Nrf2 displayed in Figure 3.3b. This allows newly synthesized Nrf2
to enter the nucleus.21 Once in the nucleus, Nrf2 binds small Maf proteins and various other
transcription factors where it acts upon the antioxidant response element/electrophile
response element in the regulatory region of its target genes.29 This causes the activation
for various target genes that can result in the following; glutathione synthesis, elimination
of ROS, xenobiotic metabolism, and drug transport.30
The structure of Nrf2 is poorly characterized. A solution NMR structure shows that
isolated Neh1 (residues 405-483) adopts a helical conformation (Figure 3.4). NMR data
suggest that the N-terminal domain (Neh2) is intrinsically disordered.31 No other structural
information is available for the full-length protein.

Figure 3.4. Neh1solution NMR structure. Residues 405-483 of Nrf2 display a helical architecture
(pdb: 2LZ1).
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Like Nrf2, there are no full-length high-resolution structures of Keap1. Single
particle electron microscopy revealed that Keap1 resembled a ‘cherry-bob’ structure.32
Displayed in Figure 3.5 are partial crystal structures that have been determined for the BTB
and Kelch domain.33-34 Figure 3.5a shows the BTB domain consists of a three-stranded βsheet flanked by six α-helices, the first of which forms a key part of the dimerization
interface with another Keap1 protein. The Kelch domain (Figure 3.5b) is a six-bladed βpropeller where each blade of the propeller is made up of four β-strands.35 Each motif of
Nrf2 binds in a pocket at the bottom of the entrance of the β-propeller.

Figure 3.5. Partial crystal structures of Keap1. (a) Crystal structure of the BTB domain from
residues 50-179 (pdb: 4CXI). (b) Crystal structure of the Kelch domain from residues 325-609
(pdb: 2FLU).

Due to the disordered nature of Nrf2 and the complexity of studying protein-protein
interactions, investigating Nrf2 has proven to be challenging. Characterizing structural and
dynamic features of Nrf2 and its interactions with the Kelch domain is essential for
understanding how Nrf2 carries out its function. X-ray crystallography remains difficult
for full-length Nrf2 due to its disordered nature. NMR based methods have also been
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employed to study the structural and dynamic aspects,19,

36

but those experiments are

difficult due to the size and disordered nature of full-length Nrf2.
Backbone amide hydrogen/deuterium exchange (HDX) coupled with ESI-MS has
become a popular method for studying protein behaviour in solution.37-38 Regions that are
involved in hydrogen-bonding networks or are occluded from the solvent will undergo
slow exchange. In contrast, regions that are disordered or solvent accessible will undergo
fast exchange upon protein exposure in D2O-based solvent. The exchange process is due
to dynamic fluctuations that disrupt amide hydrogen bonding. By measuring deuterium
incorporation, it is possible to determine the relative flexibility of backbone segments of a
protein (refer to Chapter 1 where this has been discussed in more detail).
HDX-MS has become a popular tool to interrogate IDPs that remain challenging to
characterize by other techniques.2,

39-41

Therefore, HDX-MS is a promising avenue to

investigate the disordered full-length Nrf2. Since HDX-MS has almost no size limitation,
investigating the Nrf2-Keap1 complex can easily be achieved. Using this approach will
provide an understanding of the dynamic nature of full-length Nrf2 (see Figure 3.1) and
pinpoint regions in Nrf2 and the Kelch domain (see Figure 3.5b) that change upon
interacting with one another.
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3.2 Experimental

3.2.1 Protein Expression and Purification
The protein used in this work was expressed and purified by Nadun Karunatilleke
from Dr. James (Wing-Yiu) Choy’s Laboratory in the UWO Biochemistry Department.
Nrf2 and the truncated Kelch domain were cloned into the expression vector pDEST17.
Nrf2 was isolated from E. coli (Rosetta 2(De3) pLysS). The Kelch domain was isolated
from E. coli (BL21). Both proteins were purified using Ni-Sepharose affinity
chromatography. The protein concentration of Nrf2 and Kelch domain were calculated by
the Lowry and Bradford protein assay, respectively. These concentration values were
confirmed by amino acid analysis.
Final protein stock solutions contained 50 mM phosphate buffer, 100 mM NaCl,
and 1 mM dithiothreitol (DTT). Na2PO4, NaH2PO4, NaCl, and D2O were purchased from
Sigma Aldrich (St. Louis, MO).

3.2.2 Hydrogen/Deuterium Exchange-Mass Spectrometry
All HDX experiments were performed in 50 mM sodium phosphate buffer and 100
mM NaCl at pH 7 in 90% D2O with a final protein concentration of 2 μM for Nrf2 and
Kelch. In the binding experiments Nrf2 protein concentration was kept constant at 2 μM
and the Kelch protein concentration was varied from 2, 4, and 6 μM in the 1:1, 1:2, and 1:3
(Nrf2:Kelch) binding experiments, respectively. Aliquots were removed at time points 0.1,
0.2, 0.4, 5, 30, and 60 minutes. The various aliquots were quenched by lowering the pH to
2.5 using 20% (v/v) formic acid (FA) and flash freezing in liquid N2. The samples were
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thawed and injected into a nanoACQUITY UPLC equipped with HDX technology
(Waters, Milford, MA). Digestion was carried out online using a POROS pepsin column
(2.1 mm x 30 mm) from Life Technologies/Applied Biosystems (Carlsbad, CA) held at 15
ᵒC. Subsequently, the peptides were trapped on a C18 BEH130 VanGuard column (5 mm x
1 mm, 1.7 μm) for three minutes at 80 μL/min. The peptides were separated on a C 8 (50
mm x 2.1 mm, 1.7 μm) at a flow rate of 100 μL/min using a water/acetonitrile gradient
acidified with 0.1 % FA.
The LC outflow was directed to a 2nd generation Synapt Q-TOF G2 instrument
(Waters, Milford, MA). The instrument was operated in positive ion mode at 2.8 kV and a
cone voltage of 20.0 V. The desolvation and source temperatures were set to 250 ᵒC and
80 ᵒC, respectively. Mass spectra were acquired for 25 minutes and obtained within 502000 m/z range in resolution mode. Ion mobility separation was employed to aid in
separating overlapping isobaric peaks.

3.2.3 HDX Data Analysis
Peptide identification was performed using three separate label free data
independent acquisitions (MSE). MSE data were analyzed using Protein Lynx Global
Server 2.5.3. DynamX 3.0 was used for HDX data analysis and all computer assignments
were verified manually. Deuterium uptake levels were corrected for artificial in-exchange
and back-exchange using a protein sample which exhibits the minimum exchange that
could possibly occur (m0) and a fully deuterated protein sample (m100), respectively.
Deuterium uptake for each peptide at exposure time t, was calculated according to:
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% D(t) =

𝑚𝑡 −𝑚0
𝑚100 −𝑚0

x 100%

Online digestion yielded 101 peptides for Nrf2 resulting in 86.3% coverage shown in
Figure 3.6. Online digestion of Kelch yield 109 peptides resulting in 99.7% coverage
displayed in Figure 3.7.
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Figure 3.6. Nrf2 peptide coverage. Online digestion yielded 101 peptides resulting in 86.3%
coverage. All seven domains were covered in the HDX-MS experiments. The sequence colouring
corresponds to the domain colours in Figure 3.1.

87

Figure 3.7. Kelch sequence coverage. Online digestion yielded 109 peptides resulting in 99.7%
coverage.

3.3 Results and Discussion
It has remained difficult to study full-length Nrf2 and its interaction with the Kelch
domain using X-ray crystallography and NMR methods due to its large size and dynamic
nature. Here, HDX-MS is used to gain insights into structural and dynamic aspects of Nrf2
and its interaction with the Kelch domain.
Experiments show that the Neh2 domain of Nrf2 can bind to the full-length Keap1
at low nanomolar concentrations.31, 42 Initial isothermal calorimetry from our collaborators
showed the Kd values of the ETGE and DLG binding motifs in the full-length Nrf2
construct when bound to truncated Kelch are 3.01, and 274 nM, respectively owing to more

88

electrostatic interactions between Kelch and ETGE motif.43 These values are consistent
with what has been demonstrated in the literature.31

3.3.1 Effects of Kelch on Nrf2
Initial HDX-MS data showed that free full-length Nrf2 is highly dynamic
throughout its entire sequence as seen from the data in Figure 3.8 (black). Fast HDX
kinetics are observed throughout the protein, where all peptides exhibit 100% deuteration
after 12 seconds. Surprisingly, the Neh1 domain exhibits no signs of a helical architecture
that was displayed in its NMR structure.44 This could be an artifact of the high
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Figure 3.8. Nrf2 uptake plots of the seven different domains for free Nrf2 (black), 1:1 (red). 1:2
(blue), and 1:3 (gray) Nrf2:Kelch.
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concentration of arginine (50 mM) that was used in the solution NMR experiment where
the Neh1 structure was generated.44 Arginine has been found to suppress protein
aggregation by increasing protein stability.45 This could be a possible reason for the
absence of the helical structure in this work.
The effects of Kelch on the structure and dynamics of full-length Nrf2 was also
investigated. Various conditions were tested. The Nrf2 concentration was held constant at
2 μM, while the Kelch concentration varied from 2, 4, and 6 μM which correspond to Nrf2Kelch ratios of 1:1, 1:2, and 1:3, respectively. By testing these different ratios of protein
concentration, it is possible to selectively populate the high affinity motif or both binding
sites due to the different Kd values of the ETGE and DLG motifs. In Figure 3.8, major
HDX changes are observed in the Neh2 domain when Kelch is added. Upon 1:1 addition
of Kelch (red), a large reduction in HDX kinetics is displayed in the ETGE binding motif
and a small reduction in deuterium uptake in the DLG motif, which is consistent with their
Kd values. In a physiological setting, Nrf2 interacts with two Kelch domains. By
interrogating the 1:2 (blue) state, a large reduction in deuterium uptake is observed in the
DLG binding site and an even greater reduction in HDX in the ETGE motif. This effect
was enhanced in both binding motifs in the 1:3 state (gray). In all three states, the addition
of Kelch had no visible effect on the other domains of Nrf2.
Other experimental studies on Nrf2’s binding motifs with the Kelch domain have
shown to display consistent results with the observed HDX data presented in this work.
The DLG motif (29-31) and ETGE motif (79-81) insert into the bottom of the Kelch
domain in a similar manner. Data has shown that the ETGE peptide adopts a β-turn
conformation that is buried into the binding surface of the Kelch domain.25, 35 Various
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electrostatic interactions are made by Glu79 and Glu82. Another X-ray structure
investigated the DLG region complexed with Kelch and showed that this peptide formed
an N-terminal helix from residues 19-25 and two short 310 helices from residues 28-30 and
34- 37.34 HDX is not able to differentiate between solvent accessibility and H-bonding.
Therefore, the strong protection patterns observed in these regions when Nrf2 interacts
with Kelch could be due to solvent occlusion as the binding motifs insert into the bottom
pocket of Kelch, or due to secondary structure formation as shown from previous work.25,
34-35

Figure 3.9 shows the HDX % difference plots at t = 6 s of Nrf2 in the 1:1, 1:2, and
1:3 states. These maps use a scale where blue regions indicate less HDX than free Nrf2;
red regions are indicative of more HDX (more dynamic) than free Nrf2. These plots clearly
display the enhanced effect that is observed in the Neh2 domain by increasing the Kelch
concentration. Surprisingly, all the other domains experience slightly more flexibility at
the earliest time point upon binding the Kelch domain (red hues). These data suggest that
when full-length Nrf2 binds to the Kelch domain the rest of the protein becomes somewhat
more dynamic. Other IDPs that were studied using a full-length construct have also shown
a more dynamic nature upon target binding distant from the binding site.40 Due to the
absence of studies on full-length Nrf2, this highlights a limitation when using truncated
proteins in biophysical studies.
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Figure 3.9. HDX % difference plots of Nrf2 when it interacts with Kelch in the 1:1, 1:2, and 1:3 states
compared to free Nrf2 at t = 6 s. The side panel indicates the domain location as shown in Figure 3.1
(same colouring).
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3.3.2 Effects of Nrf2 on the Kelch Domain
The effects of Nrf2 on Kelch can also be investigated. The deuteration kinetics of
free Kelch (black) displayed in Figure 3.10 show slow uptake patterns throughout its entire
sequence, consistent with its tightly folded β-propeller structure.35 Previous X-ray data
using truncated peptides of Nrf2 showed that the ETGE motif forms various hydrogen
bonds when it interacts with Kelch. Padmanabhan et al demonstrate that Glu79 forms Hbonds with Kelch residues Arg415, Arg483, and Ser508, whereas Glu82 H-bonds with
residues Ser363, Asn382, and Arg380.25,

46

These regions may be of interest when

investigating the effect Nrf2 has on Kelch since H-bonding could result in stabilization of
the Kelch domain.
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Figure 3.10. % Deuteration uptake plots for free Kelch (blue), 1:1 (red), and 2:1 (blue) Kelch:Nrf2.

In the 1:1 and 2:1 (Kelch:Nrf2) states, the overall HDX kinetics remained the same
throughout the entire Kelch sequence. Peptides 335-341, 375-393, and 571-581 are the
only three peptides that show a slight reduction in deuterium uptake when Nrf2 is added.
Peptide 375-393 contains residue Asn382 that is found to form an H-bond with Nrf2. The
HDX data is consistent with this as peptide 375-393 display a reduction in deuterium
uptake indicative of protection of this site.
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To understand the global effect Nrf2 has on Kelch, the HDX % difference of the
1:1 state was plotted at time points 0.1, 0.4, 30 minute compared to free Kelch. This is
displayed in Figure 3.11 using a top and side view of Kelch. As stated above, the maps
use a scale where blue regions indicate less HDX than free Kelch; red regions are indicative

Figure 3.11. HDX % difference of Kelch when Nrf2 is added at 0.1, 0.4, and 30 mins compared to
free Kelch.
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of more HDX (more dynamic) than free Kelch. At 0.1 and 0.4 minutes a large reduction in
deuterium uptake is observed in peptide 275-293 consistent with H-bond formation of this
site when the Kelch domain interacts with Nrf2. This strong effect disappears at the 30minute time point. Overall, the data show that there is a general stabilization of the entire
Kelch domain when Nrf2 binds as a result of a reduction in deuterium uptake. Interestingly,
this may be the first account of this global stabilization of the Kelch domain when it
interacts with full-length Nrf2.
The data presented in this Chapter highlight the importance of using full-length
proteins to investigate their structural and dynamic characteristics using biophysical
techniques. Earlier investigations using full-length Nrf2 have been unsuccessful. Using the
full-length Nrf2 construct in this work uncovers important structural and dynamic
characteristics that provide insights into Nrf2’s biological role. It was uncovered that free
Nrf2 is highly disordered throughout its entire sequence, contrary to what has been reported
before.44 When Nrf2 interacts with the Kelch domain, a large reduction in deuterium uptake
is observed in the DLG and ETGE binding motifs of Nrf2. The rest of Nrf2 became slightly
more dynamic shown by an increase in HDX. It was also found that when Nrf2 interacts
with Kelch, it resulted in a global stabilization of the entire Kelch domain. These findings
highlight the limitations of interrogating truncated proteins when using biophysical
techniques. Since full-length Nrf2 has not been successfully investigated previously, HDXMS has been a successful technique in providing new insights into the function of this
important protein. These findings could help in numerous applications such as drug
therapies related cancer, neurodegenerative diseases, as well as autoimmune and
inflammatory diseases where Nrf2 has been found to play an important role.
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3.4 Conclusions
HDX-MS is used in this work as a technique that allows the interrogation of large
disordered proteins and protein complexes. Full-length Nrf2 has not yet been successfully
studied to date, due to its large size and highly dynamic nature. Here, full-length Nrf2 is
investigated using HDX-MS. The data show that in the context of the full-length protein,
Nrf2 is exclusively disordered opposing what has previously been reported.44 When Nrf2
is in the presence of the Kelch domain, a large reduction in deuterium uptake is observed
in the ETGE and DLG binding motifs and the rest of the protein become slightly more
dynamic. The effect Nrf2 has on the structure of Kelch was also investigated and show that
full-length Nrf2 induces a global stabilization on the Kelch domain which has not been
reported before.
Full-length Nrf2 has continued to be difficult to study with classic high-resolution
techniques such as X-ray crystallography and NMR. However, using HDX-MS in this
work has provided insight into the dynamic disposition of Nrf2 and the effect Nrf2 and
Kelch have on each other when they interact. The findings in this work emphasize the
notable power of HDX-MS as an analytical tool. Since one third of all eukaryotic proteins
are known to be intrinsically disordered, it is imperative to understand their structural and
dynamic characteristics and how they are related to their function. HDX-MS is a promising
technique that can be utilized to study other disordered proteins and protein-protein
interactions like Nrf2.
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Chapter 4 - Conclusions and Future Work

4.1 Conclusions
Proteins are macromolecules that carry out essential biological functions.
Understanding a protein’s three-dimensional native structure is imperative to
understanding their function. In recent years, it has become clear that in addition to
structure, dynamics play a significant role for protein function.1-2 A variety of biophysical
techniques have been introduced to study protein structure and dynamics. X-ray
crystallography and NMR spectroscopy represent techniques that interrogate proteins on
an atomic scale. X-ray crystallography remains the gold standard for atomically resolved
structural data however, it only provides static snap shots.1, 3 NMR spectroscopy can probe
both structural and dynamic characteristics at near-native solution conditions, however, its
application to large protein systems remains challenging.4-5 Optical spectroscopy provides
insights into global structural changes while detailed structural features remain hidden.3, 6
Ideally, all protein studies would involve the use of high-resolution techniques, but this is
not always feasible. HDX-MS has become an indispensable analytical tool that gives
insight into both structure and dynamics in solution and that is widely applicable regardless
of system size.
In Chapter 2, rabbit muscle pyruvate kinase was investigated using HDX-MS. This
work concluded that efforts to elucidate linkages between enzyme dynamics and catalysis
via comparative measurements should be treated with caution. Dramatic changes were
observed in the extent of conformational dynamics during catalysis. However, this work
showed that these changes are not unique to catalysis, but they arise from binding
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interactions that can also be implemented in the absence of turnover. It appeared that the
magnitude of such binding-associated dynamic changes dwarfs subtle conformational
events that might be uniquely linked to enzymatic turnover.
Chapter 3 focused on interrogating the intrinsically disordered protein called Nrf2.
Full-length Nrf2 and its interaction with the Kelch domain continue to pose experimental
challenges due to their size and dynamic predisposition. HDX-MS showed that full-length
Nrf2 is quite disordered throughout its entire sequence contrary to previous proposals in
the literature generated on the basis of truncated protein constructs.7 Interactions between
Nrf2 and the Kelch domain showed a reduction in deuterium uptake for both Nrf2 binding
sites. However, the rest of Nrf2 became slightly more dynamic upon binding Kelch. Such
results have not been reported before, as full-length Nrf2 remains challenging to study.
This work highlights the limitations of using truncated proteins in biophysical studies.

4.2 Future Work

4.2.1 Application of HDX to Other Enzymes
HDX-MS has proven to be a powerful technique for probing protein structure and
dynamics. In the future, HDX-MS can be applied to other enzymes for obtaining a better
understanding of the relationship between protein dynamics and catalysis. Recent
investigations on enzymes revealed that the protein dynamics during catalysis are an
intrinsic property,8 where other studies have shown enhanced dynamics during catalysis.9
These findings may be on a case-by-case basis so investigating other enzymes using HDXMS is important for understanding the basis of protein dynamics during catalysis. Since
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HDX-MS has no upper size limit, studying the dynamics of larger enzymes that remain
challenging for other techniques is promising as well.

4.2.2 Application of HDX to Other Intrinsically Disordered Proteins
IDPs are a unique class of proteins as they lack a well-defined three-dimensional
structure. They play an important role in cancer and many neurodegenerative diseases.10-11
Since IDPs are difficult to study by other techniques, truncated segments are commonly
investigated. This work has proven that this approach is not adequate to only study
segments of IDPs. HDX-MS has demonstrated to be a key technique to study IDPs since it
routinely reports on disorder regions. Studying full-length IDPs whose structure remains
unknown, may give important insights into how they behave in solution and how they
interact with their binding partner. IDPs encompass one third of all proteins in eukaryotic
organisms, such investigations could provide important insights that can be used in drug
therapies for many human diseases.
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